The estimated Net Worth of Regina E Dugan is at least $2.37 Million dollars as of 10 April 2024. Regina Dugan owns over 17,390 units of Varian Medical Systems stock worth over $446,891 and over the last 11 years he sold VAR stock worth over $1,655,998. In addition, he makes $265,746 as Independent Director at Varian Medical Systems.
Sign up
Regina Dugan VAR stock SEC Form 4 insiders trading
Regina has made over 36 trades of the Varian Medical Systems stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 17,390 units of VAR stock worth $287,544 on 10 April 2024.
The largest trade he's ever made was selling 61,191 units of Varian Medical Systems stock on 15 October 2019 worth over $376,937. On average, Regina trades about 7,292 units every 51 days since 2014. As of 10 April 2024 he still owns at least 27,027 units of Varian Medical Systems stock.
You can see the complete history of Regina Dugan stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Regina Dugan biography
Dr. Regina E. Dugan Ph.D. serves as Independent Director of the Company. Chief Executive Officer of a stealth startup in the technology sector (February 2019—present) • ?Vice President of Engineering, Facebook, Inc., leading Building 8, a team charged with developing and delivering next generation consumer hardware to market (May 2016—January 2018) • ?Vice President of Engineering, Google, Inc., leading the Advanced Technology and Products group, a group charged with breakthrough innovations in mobile computing and accelerating the development of promising technologies to market (February 2014—April 2016) • ?Senior Vice President, Google owned Motorola Mobility LLC, a mobile technology company Google acquired in May 2012 (March 2012— February 2014) • ?Director, Defense Advanced Research Projects Agency (DARPA), a breakthrough product development organization of the U.S. Department of Defense (July 2009—March 2012) • ?Co-Founder, President and Chief Executive Officer, RedXDefense LLC, a security solutions company (2005—July 2009) • ?Co-Founder, President and Chief Executive Officer, Dugan Ventures, an investment firm (currently a non-voting partner) (2001—July 2009) • ?Other Current Public Company Board Memberships: Zynga Inc., a social game developer.
What is the salary of Regina Dugan?
As the Independent Director of Varian Medical Systems, the total compensation of Regina Dugan at Varian Medical Systems is $265,746. There are 8 executives at Varian Medical Systems getting paid more, with Dow Wilson having the highest compensation of $9,446,300.
How old is Regina Dugan?
Regina Dugan is 57, he's been the Independent Director of Varian Medical Systems since 2013. There are 7 older and 5 younger executives at Varian Medical Systems. The oldest executive at Varian Medical Systems, Inc. is David Illingworth, 66, who is the Independent Director.
What's Regina Dugan's mailing address?
Regina's mailing address filed with the SEC is C/O HEWLETT PACKARD ENTERPRISE COMPANY, 1701 E MOSSY OAKS ROAD, SPRING, TX, 77389.
Insiders trading at Varian Medical Systems
Over the last 22 years, insiders at Varian Medical Systems have traded over $57,574,967 worth of Varian Medical Systems stock and bought 500 units worth $22,595 . The most active insiders traders include Kent J Thiry, Timothy E Guertin und Dow R Wilson. On average, Varian Medical Systems executives and independent directors trade stock every 11 days with the average trade being worth of $181,124. The most recent stock trade was executed by Jesse Michael Bruff on 1 March 2021, trading 6,499 units of VAR stock currently worth $1,142,589.
What does Varian Medical Systems's logo look like?
Complete history of Regina Dugan stock trades at Zynga Inc, Hewlett Packard Enterprise Co und Varian Medical Systems
Varian Medical Systems executives and stock owners
Varian Medical Systems executives and other stock owners filed with the SEC include:
-
Dow Wilson,
Chief Executive Officer, Director -
Kolleen Kennedy,
President - Proton Solutions Division and Chief Growth Officer -
Chris Toth,
President, Chief Operating Officer -
R. Andrew Eckert,
Independent Chairman of the Board -
Jeffrey Balser,
Independent Director -
Judy Bruner,
Independent Director -
Anat Ashkenazi,
Independent Director -
Jean-Luc Butel,
Independent Director -
Regina Dugan,
Independent Director -
David Illingworth,
Independent Director -
Phillip Febbo,
Independent Director -
Michael Hutchinson,
Senior Vice President, Chief Legal Officer -
Francis Facchini,
President, Interventional Solutions Business -
Anshul Maheshwari,
Vice President, Treasurer and Investor Relations -
Michelle Le Beau,
Independent Director -
J. Michael Bruff,
Chief Financial Officer, Senior Vice President - Finance -
Magnus Momsen,
SVP, CAO, Corporate Controller -
Mark R Laret,
Director -
Jose Baselga,
Director -
John W Kuo,
SVP, Gen Counsel and Secretary -
Gary E Jr Bischoping,
SVP, Finance & CFO -
Susan L Bostrom,
Director -
Timothy E Guertin,
Director -
Clarence R Verhoef,
SVP, Finance, Corp Controller -
Venkatraman Thyagarajan,
Director -
Sunny Sanyal,
SVP and President, ICB -
Robert H Kluge,
Corporate Vice President -
Richard M Levy,
President and CEO -
Ruediger Naumann Etienne,
Director -
John Seely Brown,
Director -
Erich R Reinhardt,
Director -
Tai Yun Chen,
VP and Corporate Controller -
David W Jr Martin,
Director -
Steven A Leibel,
Director -
Kent J Thiry,
Director -
Allen S Lichter,
Director -
Samuel Hellman,
Director -
Crisanto C Raimundo,
Corporate Controller -
Terry R Lautenbach,
Director -
Joseph B Phair,
VP Admin,Gen Counsel,Secretary -
Elisha W Finney,
Corporate Vice President & CFO -
Kevin O'reilly,
SVP, President of Oncology Sys